Recombinant multi-species GET4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GET4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables protein-folding chaperone binding activity. Involved in several processes, including cytoplasmic sequestering of protein; establishment of protein localization to membrane; and proteolysis involved in protein catabolic process. Located in chromosome; cytosol; and nuclear lumen. Part of BAT3 complex. Implicated in congenital disorder of glycosylation type II. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 1110007L15Rik,C25H7ORF20,C7orf20,CDG2Y,CEE,CGI-20,Cee,Conserved edge-expressed protein,GET4,Get4,Golgi to ER traffic protein 4 homolog,RGD1311660,TRC35,Transmembrane domain recognition complex 35 kDa subunit (TRC35)

Target products collectionGo to GET4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9496-Ag-1/ GM-Tg-hg-IP9496-Ag-2 Human GET4 protein Human
GM-Tg-rg-IP9496-Ag-1/ GM-Tg-rg-IP9496-Ag-2 Rat GET4 protein Rat
GM-Tg-mg-IP9496-Ag-1/ GM-Tg-mg-IP9496-Ag-2 Mouse GET4 protein Mouse
GM-Tg-cynog-IP9496-Ag-1/ GM-Tg-cynog-IP9496-Ag-2 Cynomolgus/Rhesus macaque GET4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9496-Ag-1/ GM-Tg-felg-IP9496-Ag-2 Feline GET4 protein Feline
GM-Tg-cang-IP9496-Ag-1/ GM-Tg-cang-IP9496-Ag-2 Canine GET4 protein Canine
GM-Tg-bovg-IP9496-Ag-1/ GM-Tg-bovg-IP9496-Ag-2 Bovine GET4 protein Bovine
GM-Tg-equg-IP9496-Ag-1/ GM-Tg-equg-IP9496-Ag-2 Equine GET4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9496-Ag-1/ GM-Tg-hg-IP9496-Ag-2; GM-Tg-rg-IP9496-Ag-1/ GM-Tg-rg-IP9496-Ag-2;
GM-Tg-mg-IP9496-Ag-1/ GM-Tg-mg-IP9496-Ag-2; GM-Tg-cynog-IP9496-Ag-1/ GM-Tg-cynog-IP9496-Ag-2;
GM-Tg-felg-IP9496-Ag-1/ GM-Tg-felg-IP9496-Ag-2; GM-Tg-cang-IP9496-Ag-1/ GM-Tg-cang-IP9496-Ag-2;
GM-Tg-bovg-IP9496-Ag-1/ GM-Tg-bovg-IP9496-Ag-2; GM-Tg-equg-IP9496-Ag-1/ GM-Tg-equg-IP9496-Ag-2
Products Name GET4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GET4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GET4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.